The important fact is that PCA3 seems to be more specific for prostate cancer and not elevated due to benign prostatic hyperplasia (BPH)—unlike prostate-specific antigen (PSA) or other non-cancerous conditions [44]. The gene discussed is PCA3; the disease is prostate carcinoma.